Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iLet Bionic Pancreas Feasibility Study
NCT02701257Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2016
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Randomised, open-label trial in type 1 diabetes mellitus (T1D), sponsored by Massachusetts General Hospital. Started Mar 2016; status: terminated.
02
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02701257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02701257.